# FDA Inspection 1121346 - Northside Hospital Cherokee - January 22, 2020

Source: https://www.keypedia.com/records/fda_inspections/northside-hospital-cherokee/82e72671-970a-4f4d-84de-92d44524f481
Source feed: FDA_Inspections

> FDA Inspection 1121346 for Northside Hospital Cherokee on January 22, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121346
- Company Name: Northside Hospital Cherokee
- Inspection Date: 2020-01-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1232581 - 2024-03-05](https://www.keypedia.com/records/fda_inspections/northside-hospital-cherokee/4c6144ef-1854-4757-a898-37f5e60a8800)
- [FDA Inspection 1033964 - 2017-11-20](https://www.keypedia.com/records/fda_inspections/northside-hospital-cherokee/76e03974-d13a-4890-b049-a3694609b747)

Company: https://www.keypedia.com/companies/northside-hospital-cherokee/15f677c6-137d-419d-a016-1ea2f8d13fb3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d